[Chemotherapy of advanced prostate cancer].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001971:Bromocriptine / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003534:Cyproterone / Q000008:administration & dosage / Q000031:analogs & derivatives; D017373:Cyproterone Acetate; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D009367:Neoplasm Staging; D009919:Orchiectomy; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D001971:Bromocriptine; D017373:Cyproterone Acetate; D003520:Cyclophosphamide; D003534:Cyproterone; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate
Zur Chemotherapie fortgeschrittener Prostatakarzinome.